Context.—Cancer staging provides critical information for patients and treating physicians to
battle against cancer, predict prognosis, and guide treatment decisions. The American Joint …

Aims Current guidelines for pathology reporting on pancreatic cancer differ in certain
aspects, resulting in divergent reporting practices and a lack of comparability of data. Here …

The lack of specific and sensitive early diagnostic options for pancreatic cancer (PC) results
in patients being largely diagnosed with late-stage disease, thus inoperable and burdened …

Purpose Knowledge about pancreatic cancer (PC) biology has been growing rapidly in
recent decades. Nevertheless, the survival of PC patients has not greatly improved. The …

Abstract Background/Objective The benefit of adjuvant therapy in ampullary cancer
(AMPAC) patients following pancreatoduodenectomy (PD) is debated. The aim of this study …

Background Periampullary adenocarcinoma consists of pancreatic adenocarcinoma
(PDAC), distal cholangiocarcinoma (DC), ampullary cancer (AC), and duodenal …

Background HHLA2 is a recently discovered member of the B7-family of immune checkpoint
molecules with limited expression in normal tissues but overexpression in several types of …

Objective The aim of this study was to establish and validate an individualized nomogram for
predicting disease-specific survival (DSS) in patients with non-metastatic ampullary …

Objective This review investigates the role of adjuvant therapy (AT) and the importance of
histopathological typing in periampullary carcinoma (PAC) treatment. Background PAC is a …

Introduction Ampullary cancer is rare and as a result epidemiological data are scarce. The
aim of this population-based study was to determine the trends in incidence, treatment and …